Clinical observation for the treatment of patients with fracture and swelling pain by disposable Glauber's dressing roll

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900025292

Enrollment

Unknown

Registered

2019-08-21

Start date

2019-09-01

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with fractures and patients with swelling and pain after fracture

Interventions

Routine treatment group:Routine intravenous drip of 20% mannitol or sodium aescinate and elevation of affected limbs by 45 degrees were used.

Mirabilite external application group:Applying Traditional Bags

Mirabilite roll external application group:One-off mirabilite roll for patent application

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Fracture inclusion criteria: 1. Meet the above diagnostic criteria. 2. Medical history information is complete,no swelling caused by other systemic diseases ,it does not affect the judgement of curative effect. 3. All fractures were fresh closed fractures ,no limbs were fixed with plaster or splint.no skin damage, can fully expose the skin of the fracture site. Postoperative Fracture Surgery : 1. All of them were patients with swelling after fracture operation. 2. No other systemic diseases were found. 3. Normal coagulation function. 4. No varicose veins of lower extremities were found. 5. No abnormal pain perception in patients. 6. Mirabilite-free allergy. 7. Mental status normal, no communication barrier.

Exclusion criteria

Exclusion criteria: After fracture: 1. Poor general condition with severe diseases of other systems, a person who may cause swelling of the limbs. 2. Fracture injuries to important blood vessels. 3. Gravidas, non-compliant patient, failure to cooperate with researchers. Postoperative Fracture Surgery: 1. Patients with severe hypertension and diabetes mellitus. 2. Patients with severe systemic infections. 3. Haemorrhagic tendencies. 4. Patients with varicose veins of lower extremities. 5. Patients with malignant tumors.

Design outcomes

Primary

Measure	Time frame
Swelling improvement rate;Visual analogue scoring;	—

Countries

China

Contacts

Public ContactLiu Qixi

FujianNursing Department, Medical University Affiliated Mindong Hospital

17639518@qq.com+86 13950513386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026